We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$28.4B
AUM Growth
+$196M
Cap. Flow
-$3.1B
Cap. Flow %
-10.94%
Top 10 Hldgs %
8.25%
Holding
2,633
New
316
Increased
839
Reduced
1,040
Closed
162

Sector Composition

Rank Sector Weight
1 Financials 12.97%
2 Healthcare 12.49%
3 Technology 11.23%
4 Consumer Discretionary 9.69%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRR
1126
DELISTED
Carbo Ceramics Inc.
CRR
$2.24M 0.01%
22,613
-12,015
-35% -$1.02M
SIR
1127
DELISTED
SELECT INCOME REIT
SIR
$2.24M 0.01%
197,470
-27,755
-12% -$316K
CHRW icon
1128
C.H. Robinson
CHRW
$17.5B
$2.23M 0.01%
37,502
+5,202
+16% +$305K
MATV icon
1129
Mativ Holdings
MATV
$711M
$2.23M 0.01%
36,754
+8,350
+29% +$471K
NTAP icon
1130
NetApp
NTAP
$37.2B
$2.21M 0.01%
51,937
-223,406
-81% -$9.29M
CUB
1131
DELISTED
Cubic Corporation
CUB
$2.21M 0.01%
41,249
-19,627
-32% -$1.01M
IDXX icon
1132
Idexx Laboratories
IDXX
$46.2B
$2.21M 0.01%
44,366
+9,954
+29% +$478K
WBMD
1133
DELISTED
WebMD Health Corp.
WBMD
$2.21M 0.01%
77,233
+26,133
+51% +$815K
MENT
1134
DELISTED
Mentor Graphics Corp
MENT
$2.21M 0.01%
94,480
-111,679
-54% -$2.39M
ATW
1135
DELISTED
Atwood Oceanics
ATW
$2.2M 0.01%
39,989
+23,389
+141% +$1.32M
CMD
1136
DELISTED
Cantel Medical Corporation
CMD
$2.2M 0.01%
69,043
-10,051
-13% -$267K
SRPT icon
1137
Sarepta Therapeutics
SRPT
$1.77B
$2.2M 0.01%
46,488
+16,115
+53% +$621K
RCL icon
1138
Royal Caribbean
RCL
$85.6B
$2.19M 0.01%
57,212
+46,312
+425% +$1.74M
AMD icon
1139
Advanced Micro Devices
AMD
$789B
$2.19M 0.01%
574,900
-936,000
-62% -$3.57M
AVNT icon
1140
Avient
AVNT
$4.19B
$2.18M 0.01%
71,086
-98,073
-58% -$2.77M
SBAC icon
1141
SBA Communications
SBAC
$19.5B
$2.18M 0.01%
27,102
-4,198
-13% -$318K
FF icon
1142
Future Fuel
FF
$223M
$2.18M 0.01%
+121,341
New +$1.99M
CSR
1143
Centerspace
CSR
$952M
$2.17M 0.01%
26,313
-10,275
-28% -$876K
ALR
1144
DELISTED
AlerisLife Inc
ALR
$2.16M 0.01%
41,861
+36,081
+624% +$2M
TIF
1145
DELISTED
Tiffany & Co.
TIF
$2.16M 0.01%
28,213
+16,113
+133% +$1.27M
CUBE icon
1146
CubeSmart
CUBE
$9.41B
$2.16M 0.01%
121,054
-113,800
-48% -$1.94M
MCHP icon
1147
Microchip Technology
MCHP
$46B
$2.15M 0.01%
106,974
+52,574
+97% +$1.04M
RDC
1148
DELISTED
Rowan Companies Plc
RDC
$2.15M 0.01%
58,679
+50,179
+590% +$1.8M
IDA icon
1149
Idacorp
IDA
$8.2B
$2.15M 0.01%
44,484
+19,984
+82% +$995K
EGN
1150
DELISTED
Energen
EGN
$2.15M 0.01%
28,078
+389
+1% +$25.2K

Similar funds

AQR Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, AQR Capital Management held 2,633 positions worth $28.4B, up 0.7% from $28.2B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

AQR Capital Management withdrew a net $3.1B in Q3 2013, closing 162 positions and reducing 1,040 holdings. Its most notable exit was CLEARWIRE CORP NEW CL A COM STK (DE), an estimated $67.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.

Against the trend, AQR Capital Management opened a new position in Twenty-First Century Fox, Inc. Class A worth $91.7M.

  • AQR Capital Management's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,736,469 shares worth $91.7M.
  • AQR Capital Management added most to HEALTH MGMT ASSOC INC CL-A in Q3 2013, an estimated $105M increase.
  • AQR Capital Management's biggest Q3 2013 reduction was Pfizer, cutting an estimated $112M.
  • AQR Capital Management fully exited CLEARWIRE CORP NEW CL A COM STK (DE) in Q3 2013, selling an estimated $67.1M.
  • AQR Capital Management's ten largest holdings make up 8.2% of its $28.4B portfolio in Q3 2013.
  • AQR Capital Management opened 316 new positions and closed 162 in Q3 2013.
  • AQR Capital Management's portfolio value rose 0.7% quarter-over-quarter to $28.4B.

Based on AQR Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.